$310 Million is the total value of Sio Capital Management, LLC's 63 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 57.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HCA | Sell | HCA HEALTHCARE INC | $16,208,000 | -23.7% | 134,599 | -14.4% | 5.22% | +1.9% |
| WCG | Sell | WELLCARE HEALTH PLANS INC | $13,071,000 | -26.6% | 50,435 | -19.3% | 4.21% | -2.0% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $9,864,000 | -10.3% | 122,653 | -19.1% | 3.18% | +19.8% |
| MDT | Sell | MEDTRONIC PLC | $8,766,000 | -6.7% | 80,702 | -16.3% | 2.82% | +24.6% |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $7,520,000 | -46.0% | 96,525 | -28.7% | 2.42% | -27.9% |
| ANTM | Sell | ANTHEM INC | $6,551,000 | -20.9% | 27,285 | -7.0% | 2.11% | +5.7% |
| DRNA | Sell | DICERNA PHARMACEUTICALS INC | $5,306,000 | -36.0% | 369,494 | -29.8% | 1.71% | -14.4% |
| ALXN | Sell | ALEXION PHARMACEUTICALS INC | $5,022,000 | -46.4% | 51,281 | -28.3% | 1.62% | -28.4% |
| MEDP | Sell | MEDPACE HOLDINGS INC | $4,320,000 | -64.5% | 51,401 | -72.3% | 1.39% | -52.5% |
| CERN | Sell | CERNER CORPput | $4,247,000 | -46.8% | 62,300 | -42.8% | 1.37% | -29.0% |
| HRC | Sell | HILL-ROM HOLDINGS INC | $4,228,000 | -4.2% | 40,182 | -4.7% | 1.36% | +28.0% |
| RVNC | Sell | REVANCE THERAPEUTICS INC | $3,974,000 | -24.1% | 305,664 | -24.3% | 1.28% | +1.4% |
| ITGR | Sell | INTEGER HOLDINGS CORP | $3,823,000 | -18.4% | 50,596 | -9.4% | 1.23% | +8.9% |
| ICLR | Sell | ICON PLC | $3,025,000 | -35.7% | 20,530 | -32.8% | 0.97% | -14.0% |
| SYNH | Sell | SYNEOS HEALTH INCcl a | $2,836,000 | -55.9% | 53,297 | -57.7% | 0.91% | -41.1% |
| FOMX | Sell | FOAMIX PHARMACEUTICALS LTD | $2,799,000 | -9.2% | 920,796 | -28.9% | 0.90% | +21.2% |
| HROW | Sell | HARROW HEALTH INC | $1,903,000 | -53.6% | 338,614 | -28.1% | 0.61% | -38.0% |
| UROV | Sell | UROVANT SCIENCES LTD | $1,788,000 | +2.7% | 188,842 | -14.2% | 0.58% | +37.1% |
| PFNX | Sell | PFENEX INC | $1,634,000 | +13.5% | 193,608 | -9.4% | 0.53% | +51.6% |
| LOGC | Sell | LOGICBIO THERAPEUTICS INC | $1,325,000 | -23.1% | 122,536 | -7.5% | 0.43% | +2.9% |
| CBIO | Sell | CATALYST BIOSCIENCES INC | $1,128,000 | -70.3% | 229,677 | -55.4% | 0.36% | -60.3% |
| BNGO | Sell | BIONANO GENOMICS INC*w exp 08/21/2023 | $1,002,000 | -62.7% | 1,439,612 | -5.3% | 0.32% | -50.2% |
| WST | Sell | WEST PHARMACEUTICAL SERVICES INCput | $709,000 | -42.8% | 5,000 | -49.5% | 0.23% | -23.7% |
| MEIP | Sell | MEI PHARMA INC | $435,000 | -88.5% | 258,852 | -82.9% | 0.14% | -84.6% |
| BCRX | Exit | BIOCRYST PHARMACEUTICALS INCput | $0 | – | -38,700 | -100.0% | -0.04% | – |
| OCUL | Exit | OCULAR THERAPEUTIX INC | $0 | – | -59,668 | -100.0% | -0.06% | – |
| AFMD | Exit | AFFIMED NV | $0 | – | -267,942 | -100.0% | -0.18% | – |
| CCXI | Exit | CHEMOCENTRYX INCcall | $0 | – | -100,000 | -100.0% | -0.22% | – |
| SVRA | Exit | SAVARA INC | $0 | – | -400,000 | -100.0% | -0.23% | – |
| UBX | Exit | UNITY BIOTECHNOLOGY INC | $0 | – | -100,635 | -100.0% | -0.23% | – |
| IMMU | Exit | IMMUNOMEDICS INC | $0 | – | -70,000 | -100.0% | -0.23% | – |
| SVRA | Exit | SAVARA INCput | $0 | – | -414,400 | -100.0% | -0.24% | – |
| INGN | Exit | INOGEN INC | $0 | – | -15,189 | -100.0% | -0.24% | – |
| VICL | Exit | VICAL INC | $0 | – | -1,329,657 | -100.0% | -0.27% | – |
| SENS | Exit | SENSEONICS HOLDINGS INC | $0 | – | -554,858 | -100.0% | -0.27% | – |
| GLYC | Exit | GLYCOMIMETICS INCput | $0 | – | -110,100 | -100.0% | -0.32% | – |
| ACHC | Exit | ACADIA HEALTHCARE COMPANY INCput | $0 | – | -38,400 | -100.0% | -0.32% | – |
| DOVA | Exit | DOVA PHARMACEUTICALS INC | $0 | – | -135,133 | -100.0% | -0.46% | – |
| BCRX | Exit | BIOCRYST PHARMACEUTICALS INC | $0 | – | -522,863 | -100.0% | -0.48% | – |
| EBS | Exit | EMERGENT BIOSOLUTIONS INC | $0 | – | -48,400 | -100.0% | -0.56% | – |
| SNN | Exit | SMITH & NEPHEW PLCspdn adr new | $0 | – | -76,102 | -100.0% | -0.80% | – |
| ZBH | Exit | ZIMMER BIOMET HOLDINGS INC | $0 | – | -32,630 | -100.0% | -0.93% | – |
| STRO | Exit | SUTRO BIOPHARMA INC | $0 | – | -339,059 | -100.0% | -0.93% | – |
| IDXX | Exit | IDEXX LABORATORIES INCput | $0 | – | -14,400 | -100.0% | -0.96% | – |
| NTRA | Exit | NATERA INC | $0 | – | -145,500 | -100.0% | -0.97% | – |
| UBER | Exit | UBER TECHNOLOGIES INC | $0 | – | -90,000 | -100.0% | -1.01% | – |
| GMED | Exit | GLOBUS MEDICAL INCcl a | $0 | – | -102,827 | -100.0% | -1.05% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -28,232 | -100.0% | -1.25% | – |
| CVS | Exit | CVS HEALTH CORP | $0 | – | -113,738 | -100.0% | -1.49% | – |
| UNH | Exit | UNITEDHEALTH GROUP INC | $0 | – | -29,176 | -100.0% | -1.72% | – |
| HUM | Exit | HUMANA INC | $0 | – | -28,307 | -100.0% | -1.81% | – |
| ITCI | Exit | INTRA-CELLULAR THERAPIES INCput | $0 | – | -607,800 | -100.0% | -1.90% | – |
| NVS | Exit | NOVARTIS AGsponsored adr | $0 | – | -90,870 | -100.0% | -2.00% | – |
| MRK | Exit | MERCK & CO INCput | $0 | – | -100,000 | -100.0% | -2.02% | – |
| LJPC | Exit | LA JOLLA PHARMACEUTICAL CO | $0 | – | -1,310,367 | -100.0% | -2.92% | – |
| GSK | Exit | GLAXOSMITHKLINE PLCsponsored adr | $0 | – | -379,500 | -100.0% | -3.66% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INCput | $0 | – | -2,055,700 | -100.0% | -13.25% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITED THERAPEUTICS ORD | 24 | Q4 2023 | 8.3% |
| VIKING THERAPEUTICS INC | 24 | Q3 2023 | 3.4% |
| CARDINAL HEALTH ORD | 20 | Q2 2022 | 7.2% |
| SANOFI SA | 19 | Q3 2022 | 9.8% |
| MEDTRONIC PLC | 19 | Q1 2024 | 5.2% |
| CATALYST BIOSCIENCES INC | 18 | Q3 2021 | 17.8% |
| PFENEX ORD | 18 | Q4 2019 | 5.9% |
| AEGLEA BIOTHERAPEUTICS INC | 18 | Q1 2023 | 1.1% |
| THE CIGNA GROUP | 17 | Q2 2024 | 11.0% |
| HCA HEALTHCARE INC | 17 | Q2 2022 | 5.5% |
View Sio Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aprea Therapeutics, Inc. | February 14, 2024 | 280,000 | 7.5% |
| Gracell Biotechnologies Inc. | February 14, 2024 | 25,007,900 | 5.2% |
| Modular Medical, Inc. | February 14, 2024 | 2,110,260 | 10.0% |
| Modular Medical, Inc. | February 13, 2023 | 1,091,479 | 10.0% |
| Cellectar Biosciences, Inc. | February 10, 2022 | ? | ? |
| CURIS INC | February 10, 2022 | 3,866,645 | 4.2% |
| Salarius Pharmaceuticals, Inc. | February 10, 2022 | 1,354,291 | 3.0% |
| Larimar Therapeutics, Inc. | February 16, 2021 | 188,661 | 1.2% |
| ACHIEVE LIFE SCIENCES, INC. | February 14, 2020 | ? | ? |
| Bionano Genomics, Inc | February 14, 2020 | 1,210,821 | 4.6% |
View Sio Capital Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-26 |
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-15 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
View Sio Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.